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Abstract
Signaling through the canonical NF-ͬB pathway is critical for the generation and maintenance of 
mature B-cells and for antigen-dependent B-cell activation. c-REL (rel) and RELA (rela) are the 
downstream transcriptional activators of the canonical NF-ͬB pathway. Studies of B-cells derived 
from constitutional rel knockout mice and chimeric mice repopulated with rela−/− fetal liver cells 
provided evidence that the subunits can have distinct roles during B-cell development. However, 
the B-cell-intrinsic functions of c-REL and RELA during B-cell generation and antigen-dependent 
B-cell activation have not been determined in vivo. To clarify this issue, we crossed mice with 
conditional rel and rela alleles individually or in combination to mice that express Cre-
recombinase in B-cells. We here report that, whereas single deletion of rel or rela did not impair 
mature B-cell generation and maintenance, their simultaneous deletion led to a dramatic reduction 
of follicular and marginal zone B-cells. Upon T-cell-dependent immunization, B-cell-specific 
deletion of the c-REL subunit alone abrogated the formation of germinal centers (GC), whereas 
rela deletion did not affect GC formation. T-independent responses were strongly impaired in mice 
with B-cell-specific deletion of rel, and only modestly in mice with RELA-deficient B-cells. Our 
findings identify differential requirements for the canonical NF-ͬB subunits c-REL and RELA at 
distinct stages of mature B-cell development. The subunits are jointly required for the generation 
of mature B-cells. During antigen-dependent B-cell activation, c-REL is the critical subunit 
required for the initiation of the GC-reaction and for optimal T-independent antibody responses, 
with RELA being largely dispensable at this stage.
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INTRODUCTION
Signaling through the nuclear factor-ͬB (NF-ͬB) signal transduction pathway is critical for 
the generation of a normal mature B-cell compartment and for antigen-dependent B-cell 
activation.1-3 The NF-ͬB pathway comprises two branches, a canonical (classical) and an 
alternative (non-canonical, non-classical) pathway, that transmit signals elicited by distinct 
cell surface receptors, eventually leading to the nuclear translocation of NF-ͬB transcription 
factors.4,5 c-REL, RELA and NF-ͬB1/p50 are the subunits of the canonical pathway, while 
RELB and NF-ͬB2/p52 transduce signals of the alternative pathway. In B-cells, activation of 
the canonical NF-ͬB pathway predominantly results in the nuclear translocation of c-
REL/p50 and RELA/p50 heterodimers and occurs during various stages of antigen-
independent and antigen-dependent B-cell development.1-3 Only c-REL and RELA are 
transcriptionally active as they contain transactivation domains (TAD).4,5 A large body of 
work has provided insights into the role of the NF-ͬB pathway in lymphocyte biology and 
during the antibody response; however, the B-cell-intrinsic functions of RELA and c-REL in 
the generation and maintenance of mature B-cells and during antigen-dependent B-cell 
activation remains incompletely defined due to the lack of suitable experimental systems.
Studies in which upstream regulators of the canonical NF-ͬB pathway were deleted in 
mouse B-cells have firmly established that activation of this pathway is required for the 
generation and maintenance of mature B-cells.6-9 However, the roles of the downstream 
transcription factors c-REL and RELA in this process are less well defined. Germ-line 
deletion of rela causes embryonic lethality at day 15 of gestation.10,11 Transfer of rela−/− 
fetal liver cells into irradiated SCID mice indicated that mature B-cells developed in the 
recipient mice,11,12 although analogous experiments with irradiated Rag-1−/− mice found 
only a partial reconstitution of splenic B-cells.13 In contrast, mice with germ-line deletion of 
rel or that lack the TAD of c-REL (relΔTAD/ΔTAD) are viable.14-16 These mice showed 
normal generation of mature B-cells. Results from experiments performed with chimeric 
mice repopulated with rel−/−rela−/− fetal liver hematopoietic stem cells suggested a 
requirement for both RELA and c-REL in this process.17 However, the extent to which c-
REL and RELA, either individually or in combination, contribute to mature B-cell 
development is unclear.
With regard to antigen-dependent B-cell development, the canonical NF-ͬB pathway shows 
a biphasic activation pattern during T-cell dependent B-cell activation and the germinal 
center (GC) reaction where antigen-activated B-cells undergo somatic hypermutation and 
class switch recombination.18-20 While nuclear translocation of NF-ͬB is observed rapidly 
upon B-cell activation.21,22 NF-ͬB signaling is not activated in the majority of GC B-
cells.23,24 However, the canonical NF-ͬB subunits show nuclear translocation in a small 
subset of B-cells in the light zone of the GC.24 We recently demonstrated that c-REL and 
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RELA exert distinct functions in these light zone B-cells.25 Thus, conditional deletion of rel 
in GC B-cells revealed that c-REL is required for the maintenance of the GC reaction, 
whereas RELA was found to be dispensable at this stage.25 However, rela deletion in GC B-
cells impaired plasma cell development.25 While it is clear that c-REL and RELA have 
specific roles in late B-cell development, the B-cell intrinsic functions of the separate 
subunits during the antigen-dependent B-cell activation and the initiation of the GC reaction 
have not been determined in vivo. However, this is a particularly relevant issue in the light of 
recent studies that demonstrated distinct functions for the same transcription factors in the 
early initiation of the GC reaction and later in the established GC. For example, c-MYC is 
required for the formation of the GC reaction26 and in a later developmental stage for GC 
maintenance.27 Similarly, interferon regulatory factor 4 (IRF4) controls the formation of the 
GC upon T-dependent immunization28,29 and in the established GC is required for plasma 
cell differentiation.30,31
Several observations imply critical roles for c-REL and RELA during B-cell activation. A 
recent study demonstrated that the two subunits follow a different activation pattern in B-
cells stimulated with anti-IgM in vitro,21 suggesting that RELA and c-REL may exert 
unique functions upon antigen encounter also in vivo. RELA-deficient fetal liver-derived B-
cells proliferated similarly to wild-type B-cells upon mitogenic stimulation in vitro.12 In 
contrast, c-REL-deficient B-cells showed defects in activation and proliferation following 
mitogenic stimulation in vitro,14-16 and rel−/− and relΔTAD/ΔTAD mice displayed an impaired 
T-dependent B-cell response in vivo. Accordingly, constitutional rel knockout mice were 
characterized by the appearance of smaller GCs relative to control mice.15,32 Since rel−/− T-
cells also have impaired activation and proliferation upon T-cell receptor stimulation in 
vitro,14 it is unclear to what extent the defective T-dependent B-cell response and GC 
formation are due to the loss of c-REL function in B-cells.
We here deleted rel and/or rela conditionally in B-cells in order to unequivocally identify the 
specific, B-cell-autonomous roles of c-REL and RELA in the generation and maintenance of 
mature B-cells and in T-dependent and T-independent immune responses in vivo. We found 
that whereas c-REL and RELA were functionally redundant during B-cell generation and 
maintenance, c-REL deficiency in antigen-activated B-cells dramatically impaired the 
formation of GCs upon T-dependent immunization and also led to a strong reduction of T-
independent responses. Conversely, RELA deficiency in B-cells did not impede GC 
formation and led to only a modest reduction in serum immunoglobulin (Ig) levels upon T-
independent immunizations.
RESULTS
Combined c-REL and RELA deficiency leads to a severe reduction in splenic B-cells
The study of chimeric mice repopulated with rel−/−rela−/− fetal liver hematopoietic stem 
cells implicated a role for both c-REL and RELA in the generation of mature B-cells.17 To 
determine the extent of the B-cell-intrinsic requirement of c-REL and RELA in the 
generation and maintenance of mature B-cells in vivo, we crossed mice with conditional rel 
and rela alleles25 to CD19-Cre mice that express Cre-recombinase in B-cells33 to jointly 
ablate the canonical NF-ͬB subunits in B-cells. We observed a marked reduction in the 
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fraction and cell number of splenic B-cells in relfl/flrelafl/flCD19-Cre mice vs. 
relfl/+relafl/+CD19-Cre and CD19-Cre control mice (Fig. 1A,B). B220+ cells comprised 
~31% of total splenocytes in relfl/flrelafl/flCD19-Cre mice vs. ~52% and ~48% in 
relfl/+relafl/+CD19-Cre and CD19-Cre control mice, respectively, and, in total cell numbers, 
~7×106 B220+ cells were present in relfl/flrelafl/flCD19-Cre mice compared to ~24×106 and 
~29×106 B220+ cells in the control mice. In the conditional mice, rel and rela deletion is 
concomitantly linked to the expression of an eGFP gene,25 which allows the tracking of the 
rel/rela-deleted B-cells in the tissues. Analysis for eGFP expression among B-cells of 
relfl/flrelafl/flCD19-Cre mice revealed distinct eGFP+ and eGFP− peaks of equal proportions 
(~49% eGFP+ vs. ~51% eGFP− B-cells; Fig. 1C); in contrast, ~67% of B-cells of 
relfl/+relafl/+CD19-Cre mice were eGFP+ (Fig. 1C). This indicates that eGFP+ B-cells 
double-deficient for c-REL and RELA were outcompeted by eGFP− B-cells that escaped 
Cre-deletion. Rel/rela-deleted eGFP+ B-cells therefore represented only ~14% of total 
splenocytes in relfl/flrelafl/flCD19-Cre mice compared to ~52% observed in the CD19-Cre 
control mice (total cell numbers, ~3×106 rel/rela-deleted eGFP+ B-cells were present in 
relfl/flrelafl/flCD19-Cre mice vs. ~29×106 B-cells in the control mice) (Fig. 1A,B).
Immunohistochemistry (IHC) analysis of spleen sections for IgM and CD3 revealed that, in 
line with the severely reduced B-cell fraction observed by flow cytometry, 
relfl/flrelafl/flCD19-Cre mice had fewer B-cell follicles within the splenic white pulp relative 
to relfl/+relafl/+CD19-Cre and CD19-Cre control mice (Fig. 2A). The B-cell follicles in 
relfl/flrelafl/flCD19-Cre mice were also more heterogeneous in size compared to the controls. 
Together, the simultaneous, B-cell-specific deletion of rel and rela leads to a severe 
reduction in the number of splenic B-cells that is reflected by abnormalities in the 
architecture of the white pulp.
Counterselection against rel/rela-deleted marginal zone (MZ) B-cells
To investigate whether B-cell-specific ablation of c-REL or RELA individually or in 
combination affects the development of mature B-cell subsets in the spleen, we performed 
flow cytometry analysis for CD23 and CD21 expression on splenocytes from relfl/flCD19-
Cre, relafl/flCD19-Cre and relfl/flrelafl/flCD19-Cre and littermate controls to determine the 
fractions of FO B-cells (B220+CD23+CD21int) and marginal zone (MZ) B-cells 
(B220+CD23−CD21hi). With regard to the single conditional knockouts, the results revealed 
only minor (c-REL cohort) or no significant (RELA cohort) differences in the fractions of 
FO and MZ B-cell subsets (Suppl. Fig. 1), or in the fractions of IgM+IgDhi vs. IgMhiIgDlo 
B-cells (data not shown), among relfl/flCD19-Cre or relafl/flCD19-Cre mice and the 
corresponding heterozygous and wild-type controls. In accordance, analysis of H&E stained 
sections showed normal splenic architecture in both mouse models (data not shown). These 
results are in line with earlier observations based on the analysis of constitutional knockout 
mice that c-REL and RELA have redundant functions in the generation and maintenance of 
mature B-cells.11,12,14-16
In contrast to the single conditional knockouts, relfl/flrelafl/flCD19-Cre mice displayed a 
reduced fraction of FO B-cells compared to relfl/+relafl/+CD19-Cre and CD19-Cre mice 
(~43% vs. ~77%), with no significance increase in the fraction of MZ B-cells (Suppl. Fig. 
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2). However, analysis of eGFP+ vs. eGFP− cells in the MZ B-cell compartment of 
relfl/flrelafl/flCD19-Cre mice revealed a strong counterselection against rel/rela-deleted MZ 
B-cells, which surpassed that observed in the FO B-cell compartment (Fig. 2B). Specifically, 
only ~26% of MZ B-cells in these mice were eGFP+ (and thus rel/rela-deleted) compared 
with ~48% of FO B-cells. In accordance with the flow cytometry results, IHC analysis of 
splenic sections revealed that the majority of B-cells in the MZ of relfl/flrelafl/flCD19-Cre 
mice were eGFP-negative, in contrast to B-cells in the follicular area that mostly stained for 
eGFP (Fig. 2C). This severe counterselection against rel/rela-deleted MZ B-cells is 
consistent with the published observation that deletion of upstream regulators of the 
canonical NF-ͬB pathway causes impaired development and/or persistence of MZ B-
cells.1,2,9
Mature B-cells require c-REL and RELA for their survival—To determine whether 
c-REL/RELA deficiency in mature B-cells impairs survival in vitro, we stimulated B-cells 
from relfl/flrelafl/flCD19-Cre or CD19-Cre control mice with B-cell activating factor (BAFF), 
which is required for the survival of mature B-cells,34 for three days. While BAFF is a 
strong activator of the alternative NF-ͬB pathway, it partly signals also through the 
canonical pathway,35,36 and it was recently shown that c-REL and RELA indeed undergo 
nuclear translocation in B-cells following BAFF stimulation.37 The results showed 
significantly enhanced cell death in the cultures of c-REL/RELA-deficient vs. control B-
cells in response to BAFF stimulation (~70% vs. ~27% by propidium iodide (PI) staining 
and ~ 60 % vs. ~15% by annexin V/7AAD staining) (Fig. 3). These findings provide 
additional evidence that the canonical NF-ͬB pathway transmits signals derived from 
BAFF-mediated activation35-37 and may explain in part the importance of canonical NF-ͬB 
signaling for mature B-cell maintenance.6,7
Combined c-REL and RELA deficiency does not impair B-cell maturation in 
the bone marrow—In CD19-Cre mice, the Cre recombinase is expressed from the pre-B 
cell stage in the bone marrow (BM) on. Therefore, we were able to determine whether the 
reduction in mature B-cells in the spleen may be the result of a defect during B-cell 
maturation in the BM of relfl/flrelafl/flCD19-Cre versus relfl/+relafl/+CD19-Cre and CD19-
Cre mice by flow cytometric analysis for pro-B (CD93hiB220intIgM−), pre-B 
(CD93hiB220intIgM+) and mature (CD93loB220+) B-cells. We observed that both the 
fraction and cell number of immature B-cells did not differ among the genotypes (Suppl. 
Fig. 3). However, in accordance with the observed reduction of mature B-cells in the 
periphery, mature B-cells were significantly reduced in the BM of relfl/flrelafl/flCD19-Cre 
mice compared to the controls (~6% compared to ~14% and ~11% in the control mice; and 
in total cell numbers ~0.6×106 compared to ~1.7×106 and ~1.5×106 in the controls; Suppl. 
Fig. 3). These results demonstrate that c-REL and RELA are redundant during the 
generation of B-cells in the BM in a B-cell intrinsic fashion, extending previous findings on 
chimeric mice repopulated with rel−/−rela−/− fetal liver hematopoietic stem cells that 
concluded that the combined absence of c-REL and RELA did not perturb the development 
of B-cell progenitors in the BM.17
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Mature B-cells are characterized by the expression of low levels of the CD24 (heat stable 
antigen, HSA) cell surface antigen.38 Consistent with the strong reduction of mature B-cells 
in the spleen of relfl/flrelafl/flCD19-Cre mice, these mice were characterized by a small 
fraction of B220+CD21intCD24lo FO B-cells compared to the control mice (~23% compared 
to ~70% and ~58% in the control mice; Suppl. Fig. 4). Instead, most splenic B220+ cells in 
relfl/flrelafl/flCD19-Cre mice were CD24hi immature B-cells (~48% compared to ~16% and 
~26% in the control mice; Suppl. Fig. 4), a population that comprises transitional B-cells 
which are the precursors of mature B-cells. Transitional (T) B-cells are further distinguished 
into recent immigrants from the BM (transitional 1; T1) that differentiate into T2 and T3 B-
cells.39
Combined c-REL and RELA deficiency leads to a developmental block at the T1 stage
To determine whether the canonical NF-ͬB subunits are functionally required during the B-
cell transitional phase (T1 to T3) development, we analyzed splenic B-cells from 
relfl/flrelafl/flCD19-Cre and control mice for their expression of CD93+IgMhiCD23− (T1), 
CD93+IgMhiCD23+ (T2), and CD93+IgMloCD23+ (T3) B-cells.39 We found a significantly 
increased fraction of T1 B-cells with a concomitant reduction in the populations of T2 and 
T3 B-cells in relfl/flrelafl/flCD19-Cre mice compared to the CD19-Cre littermate controls 
(~40% vs. ~20% T1 B-cells, ~33% vs. ~52% T2 B-cells, and ~7% vs. ~15% T3 B-cells) 
(Fig. 4A). Of note, in contrast to what we observed for the MZ B-cells (Fig. 2B), there was 
no counterselection of rel/rela-deleted eGFP+ T1 cells in relfl/flrelafl/flCD19-Cre vs. 
relfl/+relafl/+CD19-Cre mice (~83% were eGFP+ in both genotypes; Fig. 4B). To further 
characterize the block in the T1 to T2 transition, we determined the T1/T2 correlation as 
described by Derudder et al.9 which in normal mice is positive as T2 cells arise from T1 
cells.39 As expected, we observed a positive T1/T2 correlation for the CD19-Cre and 
relfl/+relafl/+CD19-Cre control mice, which however was not observed for the 
relfl/flrelafl/flCD19-Cre mice (Suppl. Fig. 5A). Also, since CD23—which is used along with 
other markers to identify transitional B-cells—is a potential NF-ͬB target gene,40 we used 
CD93 (AA4.1), which is expressed at lower levels on T2 cells,41,42 as an independent 
marker to confirm the identity of the T1 and T2 B-cell subsets.9 We found that 
relfl/flrelafl/flCD19-Cre mice harbor a significantly reduced fraction of CD93lo cells among 
T2 cells compared to the control mice (Suppl. Fig. 5B). In addition, we observed that T1 B-
cells occurred at equal numbers across all genotypes (~1.4×106, ~1.4×106 and ~1.5×106 in 
relfl/flrelafl/flCD19-Cre, relfl/+relafl/+CD19-Cre and CD19-Cre mice, respectively, Fig. 4A), 
indicating normal generation up to the T1 stage in relfl/flrelafl/flCD19-Cre mice. Together, 
these findings reveal the importance of a c-REL/RELA-controlled biological program at this 
B-cell developmental stage, in agreement with the results from studies in which the deletion 
of upstream components of the canonical NF-ͬB pathway caused a block in the T1 stage of 
B-cell development.8,42 The underlying mechanism for the T1 to T2 block upon combined 
c-REL and RELA-deficiency in B-cells remains to be determined. Since T1 cells do not 
proliferate,39 the T1 to T2 block is unlikely to be associated with cell cycle control. 
Interestingly, the recent finding that a bcl2-transgene was unable to rescue the T1 to T2 
block observed in NEMO-deficient mice9 (NEMO is an upstream regulator of the canonical 
pathway ultimately resulting in c-REL and RELA nuclear translocation) suggests that 
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activation of the canonical NF-ͬB pathway may be required for a developmental transition 
rather than cell survival.
c-REL is required for the formation of GCs in a B-cell intrinsic fashion
To determine the B-cell-intrinsic role of c-REL in the formation of GCs upon T-dependent 
B-cell activation, relfl/flCD19-Cre, relfl/+CD19-Cre and CD19-Cre control mice were 
immunized with the T-dependent antigen sheep red blood cells (SRBC) to induce GC 
formation, and analyzed 5 days later, i.e. when the initiation phase of the GC reaction has 
been completed and the early GC has formed.43,44 The results showed a marked reduction of 
CD95hiPNAhi (Fig. 5A) and BCL6+ (Fig. 5B) GC B-cells in the spleens of relfl/flCD19-Cre 
mice, with a concurrent reduction in rel-deleted (eGFP+) GC B-cells compared to 
relfl/+CD19-Cre mice (Fig. 5A). Similarly, the generation of total and eGFP+ splenic plasma 
cells was strongly impaired at this time-point in relfl/flCD19-Cre compared to relfl/+CD19-
Cre and CD19-Cre control mice (Fig. 5C). These findings indicate that c-REL is required 
for the formation of GCs and for the extrafollicular plasma cell response upon T-dependent 
immunization.
RELA is dispensable for the formation of GCs
The embryonic lethality of rela−/− mice10 practically impeded the study of RELA's B-cell-
intrinsic function in antibody responses in vivo. To determine the role of RELA in T-
dependent B-cell responses, we immunized relafl/flCD19-Cre, relafl/+CD19-Cre and CD19-
Cre control mice with SRBC. In contrast to what we observed upon rel deletion, 
relafl/flCD19-Cre mice mounted a GC response similar to control mice 5 days after SRBC-
immunization (Fig. 5D,E). Accordingly, the fraction of eGFP+ GC B-cells was similar in 
relafl/flCD19-Cre and relafl/+CD19-Cre mice (Fig. 5D). Also, relafl/flCD19-Cre mice 
generated equal amounts of splenic plasma cells compared to relafl/+CD19-Cre and CD19-
Cre control mice (Fig. 5F), and showed similar fractions of eGFP-expressing plasma cells 
compared to relafl/+CD19-Cre mice (Fig. 5F). Thus, RELA seems to be dispensable for both 
the formation of GCs and the generation of extrafollicular plasma cells during the T-
dependent immune response.
Mice with B-cell-specific deletion of c-REL show strong impairment of T-independent type-
II and type-I antibody responses
To investigate the roles of c-REL and RELA in T-independent type-II responses against 
polysaccharides, relfl/flCD19-Cre or relafl/flCD19-Cre and the corresponding heterozygous 
and CD19-Cre control mice were immunized with the hapten 4-hydroxy-3-nitrophenyl 
acetyl (NP) conjugated to aminoethyl carboxymethyl (AECM)-Ficoll and assessed for NP-
specific IgM and IgG3 serum titers 7 days later. This analysis showed a strong reduction (5 
to 10-fold) in both NP-specific IgM and IgG3 serum titers in relfl/flCD19-Cre mice 
compared to relfl/+CD19-Cre and CD19-Cre mice (Fig. 6A). relafl/flCD19-Cre mice showed 
a less severe (~2-fold) reduction in NP-specific IgM titers, and no significant changes in the 
corresponding IgG3 titers (Fig. 6B).
Type-I T-independent B-cell responses are characterized by the co-activation of antigen-
specific B-cells through Toll-like receptors (TLRs) such as TLR4, the receptor for LPS. We 
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immunized relfl/flCD19-Cre or relafl/flCD19-Cre and the corresponding heterozygous and 
CD19-Cre control mice with NP-LPS and analyzed for NP-specific IgM and IgG3 serum 
titers 7 days later. NP-specific IgM and IgG3 serum titers in relfl/flCD19-Cre and 
relfl/+CD19-Cre mice were strongly reduced (8 to 12-fold) compared to CD19-Cre mice 
(Fig. 6C), implying that the previously observed reduction in NP-specific IgG3 serum titers 
upon NP-LPS immunization in rel−/− mice14 is a B-cell intrinsic effect. In contrast, 
relafl/flCD19-Cre mice showed only a 3-fold reduction in serum IgM levels compared to 
controls, but no significant changes in IgG3 levels were observed among the different 
genotypes (Fig. 6D). Together, the results indicate a more prominent role for c-REL in T-
independent type-II and type-I antibody responses in comparison to RELA.
Discussion
The B-cell intrinsic roles of the canonical NF-ͬB transcription factors c-REL and RELA in 
mature B-cell development and activation are incompletely understood. Our studies revealed 
differential roles of these subunits during distinct B-cell developmental stages. We found 
that combined, but not individual ablation of c-REL and RELA strongly impaired the 
generation of mature B-cells, indicating redundancy of the canonical subunits during this 
developmental stage. Conversely, the subunits were not functionally redundant during 
antigen-activation of B-cells, as c-REL deficiency alone strongly impaired the formation of 
GCs and T-independent antibody responses, whereas RELA was dispensable for the 
initiation of the GC reaction and only modestly impacted T-independent antibody responses.
The observation that the B-cell-specific combined deletion of rel and rela strongly impaired 
B-cell development is in keeping with previous publications that demonstrated a crucial role 
for canonical NF-ͬB signaling in the generation and maintenance of mature B-cells.6-9 A 
recent study by Derudder et al. has more precisely dissected the roles of the canonical 
pathway in these processes by deleting the upstream regulators ikk2 or nemo in different B-
cell developmental stages.9 Thus, activation through this pathway is required at the T1 stage 
of development, and—for those cells that have overcome this developmental block—also 
later in MZ B-cells for maintenance and in FO B-cells for long-term persistence.9 In 
agreement with these findings, rel/rela-deletion led to a block in the T1 to T2 transition in 
the spleen. Moreover, the spleens of relfl/flrelafl/flCD19-Cre mice were characterized by 
fewer and smaller B-cell follicles (composed predominantly of FO B-cells) and a dramatic 
counterselection against c-REL/RELA-deficient MZ B-cells (Fig. 2). Of note, Derudder et 
al. report that a bcl2-transgene rescued FO, but not MZ B-cells in mice with B-cell-specific 
deletion of nemo9. It therefore appears that, whereas c-REL and RELA may contribute to 
the maintenance of FO B-cells by upregulating BCL2 expression, in MZ B-cells, c-REL and 
RELA may be required for the establishment of a biological program beyond the control of 
cell survival.
The generation of a normal mature B-cell compartment requires activation through the 
alternative NF-ͬB pathway in addition to the canonical pathway (reviewed in ref.45). In 
accordance, we recently showed that the functional abolishment of the alternative pathway 
in B-cells via combined deletion of the downstream transcription factors RELB and NF-ͬB2 
strongly impaired the generation and maintenance of mature B-cells.46 How do the B-cell 
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phenotypes observed upon inactivation of the canonical vs. the alternative pathway compare 
qualitatively and quantitatively? By using a similar experimental strategy to conditionally 
delete the downstream transcription factors of the separate NF-ͬB pathways, we were able 
to directly compare the consequences of their inactivation on mature B-cell development. 
Three observations are evident from this comparison: First, the effects of the ablation of the 
separate pathways on the size and composition of the mature B-cell compartment were 
virtually the same (Fig. 1&2A and ref.46). In addition, relb/nfkb2-deleted and rel/rela-
deleted MZ B-cells were strongly counterselected, comprising only ~25% of MZ B-cells in 
mice of both genotypes (Fig. 2B,C and ref.46). These findings suggest that there is some 
level of complementation among the canonical and the alternative NF-ͬB pathways during 
the generation and maintenance of mature B-cells. Second, our observation that relb/nfkb2-
deleted46 and rel/rela-deleted B-cells show the same predisposition to undergo apoptosis 
when cultured with BAFF provides further evidence for the functional requirements of both 
NF-ͬB pathways in BAFF signaling.8,37 Third, whereas c-REL and RELA were functionally 
redundant during the generation and maintenance of mature B-cells, single ablation of 
RELB or NF-ͬB2 in B-cells did impair B-cell development—albeit to a lesser extent than 
the combined deletion.46
In contrast to its redundant role during B-cell generation, c-REL was uniquely required for 
the formation of GCs upon antigen-activation in the T-dependent immune response. c-REL 
is known to be crucial for normal B-cell activation in vitro, as c-REL-deficient B-cells 
showed impaired proliferation in response to several mitogenic stimuli,14-16 a finding which 
is supported by the observation that BCR-stimulation led to a fast nuclear translocation of c-
REL during B-cell activation.21 Our previous observation that CD40+IgM-stimulated c-
REL-deficient B-cells in vitro showed defects in the establishment of a metabolic program 
that precedes proliferation25 suggests that also upon antigen-activation in vivo, c-REL may 
be required for cell growth and optimal proliferation.
A recent publication demonstrated that inhibition of IKK-induced proteolysis of p105, the 
precursor of p50, in murine B-cells impaired the antigen-induced formation of both GCs and 
extrafollicular plasmablasts47 similar to what we here described for rel deletion in B-cells. It 
is therefore possible that the observed phenotype in the p105 mutant mice is due to the 
inability of these mice to process p105 which thereby prevents the formation and thus 
nuclear translocation of c-REL/p50 heterodimers. Conversely, the loss of p105 (which acts 
as an inhibitory ͬB protein for c-REL and RELA) in nfkb1−/− mice may lead to enhanced c-
REL activity in B-cells, which might contribute to the increased formation of spontaneous 
GCs in aging mice lacking NF-ͬB1.48
c-REL shows a biphasic activation pattern during T-dependent B-cell activation and the GC 
response. c-REL undergoes rapid nuclear translocation upon B-cell activation,21,22 and, 
while there is no active NF-ͬB signaling in the majority of GC B-cells,23,24 nuclear 
translocation of c-REL is detectable within a small subset of light zone B-cells24 and we 
have previously shown that it is functionally required for the maintenance of the GC 
reaction.25 Together with our present observations, this indicates that c-REL is required at 
two stages of the GC reaction, first during the initial antigen-activation phase and later in the 
fully established GC, presumably during the selection of high-affinity B-cells. Thus, our 
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study adds c-REL to a growing list of transcriptional regulators that have critical functions 
during the formation of GCs and also in a later stage of GC development which include 
IRF4 and c-MYC.26-29 Similar to rel ablation in all B-cells (as opposed to GC-specific 
ablation), B-cell-specific deletion of irf4 dramatically impaired GC formation upon T-
dependent immunization,28,29 and c-MYC was found to be required for the initial expansion 
of GC dark zone cells within the follicle.26 Later, in the established GC, c-REL and c-MYC 
are required for the maintenance of the GC reaction,25,27 and IRF4 is essential for optimal 
class switch recombination and plasma cell differentiation.30,31 It will be interesting to 
determine in future studies to what extent these transcription factors crosstalk among each 
other49,50 in the different GC B-cell developmental stages.
By deleting rela specifically in GC B-cells, we have recently demonstrated that RELA is 
required for the generation of GC-derived plasma cells, which was reflected by a dramatic 
reduction in the serum levels of NP-specific IgG1 antibodies (>10-fold).25 While we here 
observed that relafl/flCD19-Cre mice showed only a ~2-fold reduction in NP-specific 
antibodies upon T-independent immunization, we also found that these mice generated equal 
fractions of plasma cells early in the extrafollicular response upon T-dependent 
immunization. These results suggest that RELA deficiency does not affect all types of B-cell 
activation that lead to the generation of antibody-secreting cells to the same extent. One 
possible explanation is that c-REL may partly compensate for RELA in the T-dependent 
extrafollicular and T-independent antibody response, but not during the GC response. It will 
be interesting to identify the specific transcription factor networks involved in the generation 
of antigen-secreting cells in the different arms of the humoral immune response.
Integrating the results of our present and published25 studies from the conditional deletion of 
rel and/or rela in all B-cells and GC B-cells, the following picture emerges: c-REL and 
RELA are jointly required during the generation of the mature B-cell compartment and 
appear to have non-redundant and entirely distinct functions during antigen-dependent B-
cell development. c-REL was found to be the critical subunit for the formation and 
maintenance of GCs, whereas RELA was dispensable for these processes but instead crucial 
for the differentiation or physiology of GC-derived plasma cells.25 The canonical NF-ͬB 
signaling pathway can be aberrantly activated in B-cell malignancies51,52 and in diseases 
with chronic B-cell activation.53,54 The differential requirements of c-REL and RELA in B-
cell activation and differentiation may be exploited for the development of more specific and 
thus less toxic therapies aimed at inhibiting pathogenic NF-ͬB signaling in malignant or 
chronically activated B-cells at the level of NF-ͬB subunits, the feasibility of which has 
recently been demonstrated for a small molecule inhibitor of c-REL.55 Our findings provide 
additional examples for the diverse roles of separate NF-ͬB subunits that may be relevant 
for disease therapies.56
MATERIALS AND METHODS
Mice
Conditional rel, rela and CD19-Cre mice have been described.25,33 All mice were on a 
C57BL/6 background, male or female, with an age between 2 and 4 months. Mice were 
housed and treated in compliance with the US Department of Health and Human Services 
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Guide for the Care and Use of Laboratory Animals and according to the guidelines of the 
Institute of Comparative Medicine at Columbia University. The animal protocol was 
approved by Columbia University's IACUC. To minimize the number of animals for ethical 
reasons, experiments used a number of mice per group required to provide the power to 
detect a two-fold difference between groups. Each experiment was performed multiple 
times. Littermates were randomly assigned to experimental groups according to genotype. 
Experiments were not performed in a blinded fashion. No animals were excluded from 
analysis.
Immunization
For T-dependent immune responses, mice were immunized i.p. with 1×109 SRBCs in PBS. 
For T-independent type-I and type-II responses, mice were immunized i.p. with 20 μg NP-
LPS or 30 μg of NP-AECM-FICOLL (both Biosearch Technologies), respectively. 
Peripheral blood and spleens were removed at the indicated time-points for analysis.
B-cell isolation and culture
Single cell suspensions of murine spleen were subjected to hypotonic lysis and ‘ untouched’  
B cells were purified by magnetic cell separation using the MACS B-cell isolation kit 
(Miltenyi Biotec). Purified B cells from the respective genotypes were cultured in the 
presence of 25 ng/ml BAFF (R&D Systems) at a cell density of 1.5 × 106 cells/ml.
Flow cytometry
Spleen cell suspensions or cultured B-cells were stained with the following antibodies as 
described:25,46 anti-CD138-PE (clone: 281-2); anti-CD95-PE (clone: Jo2); IgM-APC (clone 
II/41); anti-IgD-PE (clone 11-26c.2a); and anti-CD23-PE (clone B3B4) (all BD 
Pharmingen); and anti-B220-PerCP (clone: RA3-6B2); anti-CD21-APC (clone: 7E9); anti-
CD24 (HSA)-PE (clone: 30-F1), anti-CD93-PE (clone: AA4.1); and anti-CD23-Pacific Blue 
(clone: B3B4) (all Biolegend); and anti-CD19-CF594 (clone: 1D3) (BD Horizon); and PNA-
Biotin (Vector Laboratories) followed by Streptavidin-APC (BD Pharmingen). Annexin V/7-
AAD stainings were performed using the APC Annexin V Apoptosis Detection Kit with 7-
AAD (Biolegend). For DNA content analysis, cells were lysed and stained with propidium 
iodide (PI). The cells were analyzed on a FACSCalibur or a LSRII (Becton Dickinson). 
Transitional B-cells were identified by gating on B220+CD93+ lymphocytes.39 GC B-cells 
were identified by gating on B220+ lymphocytes. eGFP+ and eGFP− CD138hi plasma cells 
were identified through the lymphocyte gate. Data were analyzed using FlowJo software.
Enzyme-linked immunosorbent assay (ELISA)
For NP-LPS and NP-Ficoll immunization experiments, 96 well immune-plates (Thermo 
Fisher Scientific) were coated with NP25-BSA (Biosearch Technologies). Mouse serum 
samples were incubated for 2h at RT. Standard curves were generated using mouse IgM and 
IgG3 (Southern Biotech). Bound antibodies were detected by AP-conjugated anti-mouse 
IgM and IgG3-antibodies (Southern Biotech). Plates were developed with p-
nitrophenylphosphate (Southern Biotech) dissolved in substrate buffer.
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Histology and immunohistochemistry
Sections of splenic tissue (3 μm) were prepared after overnight fixation in 10% formalin and 
embedding in paraffin. Sections were stained with H&E for morphologic evaluation. 
Primary antibodies, rabbit anti-mouse CD3 (clone: SP7; Thermo Fisher Scientific), rabbit 
anti-GFP (Molecular Probes, Invitrogen), or rabbit anti-mouse BCL6 (clone: N-3; Santa 
Cruz) or alkaline peroxidase (AP)-conjugated anti-mouse IgM and IgG1-antibodies 
(Southern Biotech) were applied to tissue sections and incubated overnight at 4°C. 
Secondary staining with anti-rabbit HRP-labeled polymer (Dako) was performed for BCL6, 
CD3 and eGFP and developed in aminoethylcarbazole (AEC; Sigma), while AP-conjugated 
antibodies were developed in nitro blue tetrazolium chloride-5-bromo-4-chloro-3-indolyl 
phosphate (NBT/BCIP; Roche). Sections stained for BCL6/IgG1 were counterstained with 
hematoxylin. Images were acquired via a Digital Sight camera mounted to a Nikon Eclipse 
E600 microscope (Nikon).
Statistical analysis
P values were obtained using unpaired Student's t test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Combined c-REL and RELA deficiency leads to a severe reduction in splenic B-cells
(A) Percentage and (B) number of splenic B-cells in relfl/flrelafl/flCD19-Cre and the 
corresponding heterozygous and CD19-Cre control mice as determined by flow cytometry. 
(C) Flow cytometry of eGFP expression in splenic B-cells of the indicated genotypes. The 
numbers below the gate indicate the percentage of eGFP+ B-cells among of B220+ B-cells of 
relfl/flrelafl/flCD19-Cre and relfl/+relafl/+CD19-Cre mice (left). Summary of the frequency of 
eGFP+ cells among the corresponding B-cell subsets (right). (A-C) Data are cumulative 
from independent experiments (n=4-9 per group), with each symbol representing a mouse. 
Data are shown as mean ± standard deviation. Statistical significance was determined by 
Student's t test (*, P<0.05; **, P<0.01; ***, P<0.001).
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Figure 2. relfl/flrelafl/flCD19-Cre mice display fewer B-cell follicles within the splenic white pulp 
compared to controls and are characterized by counter selection against rel/rela-deleted MZ B-
cells
(A) Spleen sections from mice of the indicated genotypes were analyzed via IHC for the 
expression of CD3 and IgM. One representative mouse of three per group is shown. Original 
magnification ×40 (left) and ×100 (right). (B) The fractions of eGFP+ cells among splenic 
follicular (FO; CD23+CD21int) and marginal zone (MZ; CD21hiCD23−) B-cells in 
relfl/flrelafl/flCD19-Cre mice were determined by flow cytometry. Numbers below gates 
indicate the percentage of eGFP+ B-cells among the indicated B-cell subsets (left). Data are 
cumulative from independent experiments (n=4 per group), with each symbol representing a 
mouse, showing the frequency of eGFP+ cells among the corresponding B-cell subsets 
(right). Each symbol represents a mouse. Data are shown as mean ± standard deviation. 
Statistical significance was determined by Student's t test (**, P<0.01). (C) Spleen sections 
from mice of the indicated genotypes were analyzed by IHC for the expression of eGFP and 
IgM. FO, follicular area; MZ, marginal zone area. One representative mouse of three per 
group is shown. Original magnification ×200 (left) and ×400 (right).
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Figure 3. Combined c-REL and RELA deficiency impairs BAFF-mediated cell survival
(left) Flow cytometric analysis of BAFF-stimulated purified B-cells from relfl/flrelafl/flCD19-
Cre and CD19-Cre mice at d3 for DNA content by propidium iodide (PI) staining and 
summary of the corresponding percentage sub-G1 (bottom), and (right) for apoptotic/dead 
cells by annexin V/7AAD staining and summary of the corresponding percentage of annexin 
V/7AAD+ cells (bottom). Data are cumulative from independent experiments (n=4 per 
group), with each symbol representing a mouse. Data are shown as mean ± standard 
deviation. Statistical significance was determined by Student's t test (***, P<0.001).
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Figure 4. Combined c-REL and RELA deficiency leads to a developmental block at the T1 stage
(A) IgM and CD23 expression of CD93+ (AA4.1+) splenic B-cells from mice of the 
indicated genotypes were analyzed by flow cytometry. Numbers beside gates indicate the 
percentage of T1 (CD93+IgMhiCD23−), T2 (CD93+IgMhiCD23+), and T3 
(CD93+IgMloCD23+) B-cells (left). Summary of the frequencies of T1-T3 B-cells (right). 
Data are cumulative from independent experiments (n=4-9 per group), with each symbol 
representing a mouse. Data are shown as mean ± standard deviation. Statistical significance 
was determined by Student's t test (*, P<0.05; **, P<0.01; ***, P<0.001). (B) The fractions 
of eGFP+ cells among splenic T1 B-cells in relfl/flrelafl/flCD19-Cre and relfl/+relafl/+CD19-
Cre mice were determined by flow cytometry. Numbers below gates indicate the percentage 
of eGFP+ B-cells among the indicated B-cell subsets (left). Data are cumulative from 
independent experiments (n=4-9 per group), with each symbol representing a mouse, 
showing the frequency of eGFP+ cells among the corresponding B-cell subsets (right).
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Figure 5. Impaired GC formation in mice with deletion of rel, but not rela, in B-cells
relfl/flCD19-Cre, relfl/+CD19-Cre and CD19-Cre littermates (A-C), and relafl/flCD19-Cre, 
relafl/+CD19-Cre and CD19-Cre littermates (D-F) were immunized with SRBC and 
analyzed 5 days later. (A,D) CD95, PNA and eGFP expression by splenic B-cells were 
analyzed by flow cytometry. Numbers above gates indicate the percentage of CD95hiPNAhi 
(dot plots) or eGFP+CD95hiPNAhi (histograms) GC B-cells. (B,E) Spleen sections from 
mice of the corresponding genotypes were analyzed for the expression of BCL6 and IgG1 or 
IgM; IgG1 stainings were counterstained with haematoxylin. One representative mouse out 
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of 3 per group is shown. (C,F) CD138 and eGFP expression by splenic mononuclear cells 
from mice of the corresponding genotypes were analyzed by flow cytometry. Numbers 
below gates indicate the percentage of CD138hieGFP+ or CD138hieGFP− cells. (A,C,D,F) 
Data are cumulative from independent experiments (n=3-5 per group), with each symbol 
representing a mouse. Data are shown as mean ± standard deviation. Statistical significance 
was determined by Student's t test (*, P<0.05; **, P<0.01; ***, P<0.001).
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Figure 6. Mice with B-cell-specific deletion of c-REL show strong impairment of T-independent 
type-II and type-I antigen responses
(A) ͣ-NP IgM (left) and ͣ-NP IgG3 (right) serum response of relfl/flCD19-Cre, relfl/+CD19-
Cre and CD19-Cre mice to NP-ficoll immunization before (Pre), and 7d after immunization 
(Post) with NP-ficoll (left). (B) ͣ-NP IgM (left) and ͣ-NP IgG3 (right) serum response of 
relafl/flCD19-Cre, relafl/+CD19-Cre and CD19-Cre mice to NP-ficoll immunization before 
(Pre), and 7d after immunization with NP-ficoll (left). (C) ͣ-NP IgM (left) and ͣ-NP IgG3 
(right) serum response of relfl/flCD19-Cre, relfl/+CD19-Cre and CD19-Cre mice to NP-LPS 
immunization before (Pre), and 7d after immunization with NP-LPS (left). (D) ͣ-NP IgM 
(left) and ͣ-NP IgG3 (right) serum response of relafl/flCD19-Cre, relafl/+CD19-Cre and 
CD19-Cre mice to NP-LPS immunization before (Pre), and 7d after immunization with NP-
LPS (left). (A-D) Data are cumulative from independent experiments (n=2-7 per group), 
with each symbol representing a mouse. Data are shown as mean ± standard deviation. 
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Statistical significance was determined by Student's t test (*, P<0.05; **, P<0.01; ***, 
P<0.001).
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